CHRONIC FATIGUE SYNDROME (C.F.S.) IN A FAMILY OF DOGS, DIAGNOSIS AND TREATMENT OF THREE CASES. Walter Tarello, C.P. 42, 06061 Castiglione del Lago (PERUGIA) Italy. Email Author
A cluster of canine Chronic Fatigue Syndrome (CFS) was diagnosed according .... Physical examination revealed a complete recovery from weakness and exercise ... priory.com/vet/cfsdogs.htm
This work has been done in the Heron Veterinary Clinic of Castiglione del Lago (PERUGIA) Italy
SUMMARY A cluster of canine Chronic Fatigue Syndrome (CFS) was diagnosed according to current criteria accepted in human medicine. The fatigue and pain symptoms were associated with pyoderma, presence of micrococci-like organisms in the blood and the recovery of two vancomycin-resistant Staphylococcus xilosus strains, from a pustule and from drinking water. Thiacetarsamide sodium, was administered intravenously at low dosage (0.1 mg/Kg/day) for three days in all dogs. Clinical and hematological parameters at days 4, 7 and 10 after therapy confirmed complete remission from the syndrome, which had lasted for more than 2 years and had been treated previously with several chemotherapeutics agents. The possible role of coagulase-negative staphylococci in the aetiology of CFS and the antimicrobial action of arsenicals are discussed.
Chronic fatigue syndrome in horses: diagnosis and treatment of four cases. ... Complete recovery was obtained in a matter of days (2-10) and maintained in ...
www.geocities.com/cfsinhorses/
A report from England has suggested that Chronic Fatigue Syndrome exists in equines and constitutes an emerging veterinary problem. Preliminary epidemiological studies seem to confirm the zoonotic implications of CFS.
An arsenical drug, thiacetarsamide sodium, was administered to four horses with a diagnosis of Chronic Fatigue Syndrome (CFS), already treated unsuccessfully with different medications. The CFS-like lethargy, with accompanying symptoms and signs, of the four animals obtained a complete remission after intravenous treatment with this drug at low dosage (0.1 mg/Kg/day). No adverse side effects were ever noticed. This clinical response was associated with recovery from anaemia and decrease of muscular enzyme values in two of the four horses. In all patients, micrococci-like bacteria found before treatment adhering to the outer surface of many red blood cells, disappeared at post-treatment controls. Considerations are made on the possible action of an arsenical drug, used isolately, in the treatment of CFS.